[1] 中华医学会神经外科学分会,中国神经外科重症管理协作组慢性硬膜下血肿药物治疗专家共识[J].中华医学杂志,2020,100(8):566~572. [2] R Jiang,S Zhao,R Wang,et al.Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized Clinical Trial[J].JAMA Neurol.2018,75(11):1338~1346. [3] I P.Miah,M Herklots,G Roks,et al.Dexamethasone Therapy in Symptomatic Chronic Subdural Hematoma (DECSA-R): A Retrospective Evaluation of Initial Corticosteroid Therapy versus Primary Surgery[J].Neurotrauma,2020,37(2):366~372. [4] C He,P Xia,J Xu,et al.Evaluation of the efficacy of atorvastatin in the treatment for chronic subdural hematoma:a meta-analysis[J].Neurosurg Rev,2021,44(1):479~484. [5] Z Yao,X Hu,L Ma,et al.Dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis[J].Acta Neurochir,2017,159(11):2037~2044. [6] 陈卫良,朱祖建,苏稳,等.阿托伐他汀联合地塞米松对老年慢性硬膜下血肿钻孔引流术后复发的预防[J].中华老年心脑血管病杂志,2021,23(3):293~295. [7] 李凯,曹垒,马冲.地塞米松联合阿托伐他汀治疗慢性硬膜下血肿的疗效观察[J].中国急救医学,2018,38(z2):85. [8] 彭柏祥,吴雅玲,伍小峰,等.地塞米松联合阿托伐他汀钙对慢性硬膜下血肿钻孔引流术后疗效观察[J].临床合理用药杂志,2021,14(17):6~8. [9] 苏稳,陈瑞,朱祖建,等.地塞米松协同阿托伐他汀对慢性硬膜下血肿引流术后的治疗研究[J].浙江创伤外科,2021,26(1):1~3. [10] 王东挺,张学军,梁伟,等.阿托伐他汀联合地塞米松对慢性硬膜下血肿患者钻孔引流术后复发的影响[J].中国医学创新,2018,15(8):54~57. [11] Y Wan,D Xie,Z Xue,et al.Single Versus Double Burr Hole Craniostomy in Surgical Treatment of Chronic Subdural Hematoma: A Meta-Analysis[J].World Neurosurg,2019,131(e149~e154). [12] 张超,刘小印,王传宝,等.皮质视觉等级量表和脑萎缩指数对老年慢性硬膜下血肿的预测价值[J].中华老年心脑血管病杂志,2018,20(3):282~285. [13] Dana C Holl,Victor Volovici,Clemens M F Dirven,et al.Pathophysiology and Nonsurgical Treatment of Chronic Subdural Hematoma: From Past to Present to Future[J].World Neurosurg,2018,116:402~411. [14] Ellie Edlmann,Susan Giorgi-Coll,Peter C Whitfield,et al.Pathophysiology of chronic subdural haematoma: inflammation,angiogenesis and implications for pharmacotherapy[J].2017,14(1):108. [15] Shi M,Xiao LF,Zhang TB,et al.Adjuvant Corticosteroids With Surgery for Chronic Subdural Hematoma:A Systematic Review and Meta-Analysis[J].Front Neurosci,2021,15:786513. [16] D Wang,C Gao,X Xu,et al.Treatment of chronic subdural hematoma with atorvastatin combined with low-dose dexamethasone:phase II randomized proof-of-concept clinical trial[J].J Neurosurg.2020,1~9. |